Look up one drug

Ontario coverage, price, criteria word for word, Health Canada status and shortages for one product

Patient plan: look up a medication list

PIMECROLIMUS

All products: Limited Use (codes 383)

Other products in the same Health Canada class (D11AH) — coverage varies; not interchangeable

  • Alitretinoin (Toctino): limited Use 442, Not a benefit

Elidel · DIN 02247238 · 1% · Cr

Limited Use — Reason for Use code 383 requiredMarketed · checked 2026-09-19
StatusLimited Use — Reason for Use code 383 required
Write on scriptLU code 383 (patient must meet the criteria below)
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
Ontario Limited Use criteria — code 383
Reason for Use code 383 For use in combination with moisturizers or oral antihistamines in patients with atopic dermatitis who have failed or are intolerant to an 8 week trial of an intermediate potency topical steroid. Coverage limit: Therapy should be reassessed at 6 months. Coverage limit: LU Authorization Period: 1 year
No interchangeable product listed in the Ontario extract
Elidel · DIN 02247238 Manufacturer: Valeant Canada Ltd.; listing date 2004-04-06 Health Canada: Marketed since 2020-01-20 · brand ELIDEL · ATC D11AH02 PIMECROLIMUS · form Cream · route Topical · ingredients PIMECROLIMUS 1 %/W/W · company Bausch health, canada inc. · schedule Prescription
Check this DIN again · Health Canada product record

Elidel: Formulary list price $3.0314/unit (unit not stated in source; not the patient's cost)

Ministry pays: $3.0314 per source unit.

Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.

Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=71480 · Verify on the e-Formulary ↗ (DIN 02247238)

Source record
DIN 02247238: Elidel Raw flags: sec12=Y, sec3=Y Item: 843600084; group id 866; item number 2094; lccId 00149; manufacturer id VAL Source form: Cr; strength: 1% Recorded listing: Limited Use: paid only with a Reason for Use code and the criteria below Source prices (unrounded): $3.0314; ministry $3.0314 Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=02247238 Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=71480
Shortage status: not checked (no credentials)
Other drugs in the same formulary class (84:36 Miscellaneous Skin and Mucous Membrane Agents) and how they are covered

Matched class: 84:36 Miscellaneous Skin and Mucous Membrane Agents

Drug-class inventory only. Lists recorded Ontario formulary products, not every Canadian medication; does not recommend treatment. Covered without a code on the Ontario formulary: ACITRETIN, AZELAIC ACID, FLUOROURACIL, ISOTRETINOIN, ZINC SULFATE Some products covered without a code (check the product listing): COLLAGENASE 84:36 Miscellaneous Skin and Mucous Membrane Agents

ALITRETINOIN

· 4 products · Listed, not a benefit (2), Limited Use, codes 442 (2) · strengths: 10mg, 30mg · Cap

ACITRETIN

· 6 products · General benefit · strengths: 10mg, 25mg · Cap

AZELAIC ACID

· 1 products · General benefit · strengths: 15% · Top Gel

COLLAGENASE

· 2 products · General benefit (1), Temporary benefit (1) · strengths: 250Unit/g · 30g Pk, Oint-30g Pk

FLUOROURACIL

· 1 products · General benefit · strengths: 5% · Cr

ISOTRETINOIN

· 8 products · General benefit · strengths: 10mg, 20mg, 30mg, 40mg · Cap

ZINC SULFATE

· 2 products · General benefit · strengths: 0.5%, 10mg · Oint, Sup

BRODALUMAB

· 1 products · Limited Use, codes 553 · strengths: 210mg/1.5mL · Inj Sol-Pref Syr

CALCIPOTRIOL

· 1 products · Limited Use, codes 191 · strengths: 50mcg/g · Oint

CALCITRIOL

· 1 products · Limited Use, codes 191 · strengths: 3mcg/g · Oint

IXEKIZUMAB

· 2 products · Limited Use, codes 526 · strengths: 80mg/mL · Inj Sol-Pref Autoinj, Inj Sol-Pref Syr

RISANKIZUMAB

· 3 products · Limited Use, codes 574 · strengths: 75mg/0.83mL, 150mg/mL · Inj Sol-0.83mL Pref Syr (Preservative-Free), Inj Sol-Pref Pen (Preservative-Free), Inj Sol-Pref Syr (Preservative-Free) Source: formulary-ed43-front-matter.txt Part V; ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26; class 84:36 and 3 more
Full class listing Related classes: 84:04 Anti-Infectives, 84:06 Anti-Inflammatory, 84:28 Keratolytic Agents Same formulary class, not same indication: class membership alone does not establish equivalent uses.
What the Health Canada label says it is for
1 INDICATIONS ELIDEL (pimecrolimus) Cream 1% is indicated for:  second-line therapy for short term and intermittent long-term therapy of mild to moderate atopic dermatitis in non-immunocompromised patients 3 months of age and older, in whom the use of alternative, conventional therapies is deemed inadvisable because of potential risks, or in the treatment of patients who are not adequately responsive to or intolerant of alternative, conventional therapies. For additional safety information, please refer to WARNINGS AND PRECAUTIONS section. 1.1 Pediatrics Pediatrics ( 3 months of age): Based on the data submitted and reviewed by Health Canada, the safety and efficacy of ELIDEL cream in pediatric patients have been established; therefore, Health Canada has authorized an indication for pediatric use. 1.2 Geriatrics Geriatrics (> 65 years of age): Clinical studies of ELIDEL did not include sufficient numbers of subjects aged 65 and older to establish efficacy and safety of the drug in geriatric patients. https://pdf.hres.ca/dpd_pm/00054703.PDF PM date: January 16, 2020 Source product: ELIDEL; DIN 02247238; fetched 2026-09-10 Product monograph posted by Health Canada; excerpt for lookup only.